These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17620444)

  • 1. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes.
    Groop PH; Thomas MC; Rosengård-Bärlund M; Mills V; Rönnback M; Thomas S; Forsblom C; Taskinen MR; Viberti G
    Diabetes Care; 2007 Oct; 30(10):2706-7. PubMed ID: 17620444
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland.
    Tuomilehto J; Borch-Johnsen K; Molarius A; Forsén T; Rastenyte D; Sarti C; Reunanen A
    Diabetologia; 1998 Jul; 41(7):784-90. PubMed ID: 9686919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between hypoglycaemia and impaired hypoglycaemia awareness and mortality in people with Type 1 diabetes mellitus.
    Sejling AS; Schouwenberg B; Faerch LH; Thorsteinsson B; de Galan BE; Pedersen-Bjergaard U
    Diabet Med; 2016 Jan; 33(1):77-83. PubMed ID: 25997108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis.
    Astrup AS
    Dan Med Bull; 2011 Aug; 58(8):B4152. PubMed ID: 21827725
    [No Abstract]   [Full Text] [Related]  

  • 5. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.
    Coleman RL; Stevens RJ; Retnakaran R; Holman RR
    Diabetes Care; 2007 May; 30(5):1292-3. PubMed ID: 17290036
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes.
    Holman RR; Coleman RL; Shine BS; Stevens RJ
    Diabetes Care; 2005 Jul; 28(7):1796-7. PubMed ID: 15983339
    [No Abstract]   [Full Text] [Related]  

  • 7. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J; Forsblom C; Thorn LM; Gordin D; Saraheimo M; Groop PH;
    Diabetes; 2009 Nov; 58(11):2649-55. PubMed ID: 19651819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoproteins and diabetic nephropathy].
    Bertsch T; Aufenanger J
    Med Klin (Munich); 1998 Jan; 93(1):57-8. PubMed ID: 9505083
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of dyslipidemias in patients with diabetes and chronic kidney disease.
    Molitch ME
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1090-9. PubMed ID: 17699330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic complications: current challenges and opportunities.
    Nickerson HD; Dutta S
    J Cardiovasc Transl Res; 2012 Aug; 5(4):375-9. PubMed ID: 22752737
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.
    Thorn LM; Forsblom C; Wadén J; Saraheimo M; Tolonen N; Hietala K; Groop PH;
    Diabetes Care; 2009 May; 32(5):950-2. PubMed ID: 19196885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context.
    Gore MO; McGuire DK
    Diab Vasc Dis Res; 2009 Jan; 6(1):53-5. PubMed ID: 19156632
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.
    Wannamethee SG; Shaper AG; Lennon L
    Heart; 2004 Dec; 90(12):1398-403. PubMed ID: 15547012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular and macrovascular complications associated with diabetes in children and adolescents.
    Donaghue KC; Chiarelli F; Trotta D; Allgrove J; Dahl-Jorgensen K
    Pediatr Diabetes; 2009 Sep; 10 Suppl 12():195-203. PubMed ID: 19754630
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of Glycemic Control With Reduced Risk for Large-Vessel Disease After More Than 50 Years of Type 1 Diabetes.
    Tinsley LJ; Kupelian V; D'Eon SA; Pober D; Sun JK; King GL; Keenan HA
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3704-3711. PubMed ID: 28973526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease.
    McVeigh GE; Gibson W; Hamilton PK
    Diabetes Obes Metab; 2013 Mar; 15(3):198-203. PubMed ID: 22998614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate.
    Earle KA; Mattock M; Morocutti A; Aravanitis D; Viberti GC
    Diabet Med; 1996 Dec; 13(12):1071-2. PubMed ID: 8973890
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased red cell aggregation in diabetes mellitus: association with cardiovascular risk factors.
    MacRury SM; Lennie SE; McColl P; Balendra R; MacCuish AC; Lowe GD
    Diabet Med; 1993; 10(1):21-6. PubMed ID: 8435983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
    Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
    Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.